Prostate Cancer Coverage from Every Angle

Carmel Jo Pezaro, MB, ChB, on Prostate Cancer and PARP Inhibitors

Posted: Thursday, July 5, 2018

Carmel Jo Pezaro, MB, ChB, of Monash University, discusses the optimal integration of PARP inhibitors for prostate cancer: which test, patient, and therapy.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.